466 related articles for article (PubMed ID: 22823891)
1. Biocompatibility of mesoporous silica nanoparticles.
Asefa T; Tao Z
Chem Res Toxicol; 2012 Nov; 25(11):2265-84. PubMed ID: 22823891
[TBL] [Abstract][Full Text] [Related]
2. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
[TBL] [Abstract][Full Text] [Related]
3. Mesoporous silica nanoparticles for therapeutic/diagnostic applications.
Jafari S; Derakhshankhah H; Alaei L; Fattahi A; Varnamkhasti BS; Saboury AA
Biomed Pharmacother; 2019 Jan; 109():1100-1111. PubMed ID: 30551360
[TBL] [Abstract][Full Text] [Related]
4. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery.
Tang F; Li L; Chen D
Adv Mater; 2012 Mar; 24(12):1504-34. PubMed ID: 22378538
[TBL] [Abstract][Full Text] [Related]
5. The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo.
Huang X; Li L; Liu T; Hao N; Liu H; Chen D; Tang F
ACS Nano; 2011 Jul; 5(7):5390-9. PubMed ID: 21634407
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications.
Lee JE; Lee N; Kim T; Kim J; Hyeon T
Acc Chem Res; 2011 Oct; 44(10):893-902. PubMed ID: 21848274
[TBL] [Abstract][Full Text] [Related]
7. Mesoporous silica nanoparticles for bioadsorption, enzyme immobilisation, and delivery carriers.
Popat A; Hartono SB; Stahr F; Liu J; Qiao SZ; Qing Max Lu G
Nanoscale; 2011 Jul; 3(7):2801-18. PubMed ID: 21547299
[TBL] [Abstract][Full Text] [Related]
8. Interaction of mesoporous silica nanoparticles with human red blood cell membranes: size and surface effects.
Zhao Y; Sun X; Zhang G; Trewyn BG; Slowing II; Lin VS
ACS Nano; 2011 Feb; 5(2):1366-75. PubMed ID: 21294526
[TBL] [Abstract][Full Text] [Related]
9. Shape-mediated biological effects of mesoporous silica nanoparticles.
Hao N; Li L; Tang F
J Biomed Nanotechnol; 2014 Oct; 10(10):2508-38. PubMed ID: 25992407
[TBL] [Abstract][Full Text] [Related]
10. Mesoporous silica nanoparticles: synthesis, classification, drug loading, pharmacokinetics, biocompatibility, and application in drug delivery.
Li Z; Zhang Y; Feng N
Expert Opin Drug Deliv; 2019 Mar; 16(3):219-237. PubMed ID: 30686075
[TBL] [Abstract][Full Text] [Related]
11. Poly-L-lysine functionalized large pore cubic mesostructured silica nanoparticles as biocompatible carriers for gene delivery.
Hartono SB; Gu W; Kleitz F; Liu J; He L; Middelberg AP; Yu C; Lu GQ; Qiao SZ
ACS Nano; 2012 Mar; 6(3):2104-17. PubMed ID: 22385282
[TBL] [Abstract][Full Text] [Related]
12. Advances in Peptide Functionalization on Mesoporous Silica Nanoparticles for Controlled Drug Release.
Hu JJ; Xiao D; Zhang XZ
Small; 2016 Jul; 12(25):3344-59. PubMed ID: 27152737
[TBL] [Abstract][Full Text] [Related]
13. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
Hu X; Wang Y; Peng B
Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
[TBL] [Abstract][Full Text] [Related]
14. Effect of size on the cellular endocytosis and controlled release of mesoporous silica nanoparticles for intracellular delivery.
Gan Q; Dai D; Yuan Y; Qian J; Sha S; Shi J; Liu C
Biomed Microdevices; 2012 Apr; 14(2):259-70. PubMed ID: 22124885
[TBL] [Abstract][Full Text] [Related]
15. Mesoporous silica nanoparticles in tissue engineering--a perspective.
Rosenholm JM; Zhang J; Linden M; Sahlgren C
Nanomedicine (Lond); 2016 Feb; 11(4):391-402. PubMed ID: 26784861
[TBL] [Abstract][Full Text] [Related]
16. Mesoporous silica nanoparticles with manipulated microstructures for drug delivery.
Chen Z; Li X; He H; Ren Z; Liu Y; Wang J; Li Z; Shen G; Han G
Colloids Surf B Biointerfaces; 2012 Jun; 95():274-8. PubMed ID: 22494670
[TBL] [Abstract][Full Text] [Related]
17. Efficient functional delivery of siRNA using mesoporous silica nanoparticles with ultralarge pores.
Na HK; Kim MH; Park K; Ryoo SR; Lee KE; Jeon H; Ryoo R; Hyeon C; Min DH
Small; 2012 Jun; 8(11):1752-61. PubMed ID: 22454257
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of mesoporous silica nanoparticles.
Wu SH; Mou CY; Lin HP
Chem Soc Rev; 2013 May; 42(9):3862-75. PubMed ID: 23403864
[TBL] [Abstract][Full Text] [Related]
19. In vivo bio-safety evaluations and diagnostic/therapeutic applications of chemically designed mesoporous silica nanoparticles.
Chen Y; Chen H; Shi J
Adv Mater; 2013 Jun; 25(23):3144-76. PubMed ID: 23681931
[TBL] [Abstract][Full Text] [Related]
20. The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses.
He Q; Zhang J; Shi J; Zhu Z; Zhang L; Bu W; Guo L; Chen Y
Biomaterials; 2010 Feb; 31(6):1085-92. PubMed ID: 19880176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]